Patient Guide: A Phase 2, Open-Label, Extension Study to Evaluate Long Term Safety and Clinical Activity of Briquilimab in Participants From Jasper-Sponsored Chronic Urticaria Trials

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 19 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06736262
Status: ENROLLING_BY_INVITATION
Condition: Urticaria, Chronic Urticaria
Phase: PHASE2

Where You Can Participate

This study is available at 19 locations across the country.

Top locations include:
  • • Birmingham, Alabama
  • • Little Rock, Arkansas
  • • San Diego, California
  • • And 16 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Phase 2, Open-Label, Extension Study to Evaluate Long Term Safety and Clinical Activity of Briquilimab in Participants From Jasper-Sponsored Chronic Urticaria Trials - Join Clinical Trial NCTNCT06736262

How to Join This Clinical Trial - NCTNCT06736262

Learn how to participate in this PHASE2 trial studying an investigational therapy for Urticaria, Chronic Urticaria. Current status: ENROLLING_BY_INVITATION.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Urticaria, Chronic Urticaria. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Urticaria, Chronic Urticaria
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ENROLLING_BY_INVITATION
Study Identifier
NCTNCT06736262 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 19 locations. Find a study site near you:

Clinical Research Site

Birmingham, Alabama 35244 - United States

Status: Contact for availability

Clinical Research Site

Little Rock, Arkansas 72205 - United States

Status: Contact for availability

Clinical Research Site

San Diego, California 92123 - United States

Status: Contact for availability

Clinical Research Site

Tampa, Florida 33613 - United States

Status: Contact for availability

Clinical Research Site

Boise, Idaho 83706 - United States

Status: Contact for availability

Clinical Research Site

Normal, Illinois 61761 - United States

Status: Contact for availability

Clinical Research Site

Indianapolis, Indiana 46250 - United States

Status: Contact for availability

Clinical Research Site

Lafayette, Louisiana 70508 - United States

Status: Contact for availability

Clinical Research Site

Baltimore, Maryland 21224 - United States

Status: Contact for availability

Clinical Research Site

White Marsh, Maryland 21162 - United States

Status: Contact for availability

And 9 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Urticaria, Chronic Urticaria:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships